AI Stocks Plunge as Chinas DeepSeek Sparks Broad Market Rout EUs Critical Dependence on China Across Five Key Sectors Raises Industrial Sovereignty Concerns Japans Megabanks Post Record Profits But Analysts Flag Headwinds Ahead Consumer Sentiment Plunges to Record Low in May as Iran Conflict Intensifies Inflation Fears Jim Cramer Spotlights 4 Portfolio Stocks as AI Sector Diversification Opportunity NextDecades Rio Grande LNG Moves Toward Completion After Decade of Industry Doubt and Legal Hurdles SSM Q1 2026 Earnings WiderthanExpected Loss Amid No Revenue Disclosure CARE Q1 2026 Earnings EPS Misses Estimates by Over 85 as Stock Rises Centene CNC Q1 2026 Earnings Massive EPS Beat Shocks Estimates Stock Rises 237 Asure Software Inc ASUR Q1 2026 Earnings EPS Beats Estimates by 18 Despite Market Skepticism NUTX Q1 2026 Earnings EPS Surges Past Estimates Stock Jumps 932 MGR Q1 2026 Earnings EPS Surpasses Estimates Stock Rises BETRW Warrants Plunge 1579 as Support Level Nears Critical Test Urban Outfitters URBN Shares Slip 1 as Retail Sector Faces Headwinds Templeton Emerging Markets Income Fund TEI Gains 104 as Price Approaches Key Resistance Brookfield Renewable Partners BEP Surges 249 Renewable Momentum and Key Technical Levels Zenta Group ZGM Holds Steady at 165 as Investors Assess Key Levels Marvell Technology Stock Rises on Exceptional AI Demand and Upbeat Revenue Outlook GATX Q1 2026 Earnings EPS Beats Estimates as Railcar Leasing Portfolio Holds Steady Brown Brown Inc BRO Holds Steady Near Support as Resistance Looms Remitly Global RELY Q1 2026 Earnings Strong EPS Beat Masks Market Concerns AEON Q4 2025 Earnings Deep EPS Miss Amid PreRevenue Stage CWK Q1 2026 Earnings Earnings Per Share Exceeds Estimates Stock Rises Slightly ICU Medical Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Operational Performance PLBC Q1 2026 Earnings EPS Beat of 712 Offsets Modest Share Price Decline HEPS Q1 2026 Earnings Negative EPS and No Revenue Disclosure Weigh on Sentiment Shares Decline 387 CGON Q1 2026 Earnings EPS Miss as ClinicalStage Oncology Firm Reports No Revenue